AGIOS PHARMACEUTICALS, INC. (AGIO) Total liabilities 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) total liabilities at each fiscal year-end, per SEC filings.
$104.1MFY2025 · since FY2016: $260.5M → $104.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.1M | -14.8% |
| FY2024 | $122.2M | -3.1% |
| FY2023 | $126.1M | -8.6% |
| FY2022 | $137.9M | -5.4% |
| FY2021 | $145.8M | -67.9% |
| FY2020 | $453.5M | +81.2% |
| FY2019 | $250.2M | +46.4% |
| FY2018 | $170.9M | -28.5% |
| FY2017 | $238.9M | -8.3% |
| FY2016 | $260.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AGIO financial trends
AGIO RevenueAGIO Net incomeAGIO Net marginAGIO Gross profitAGIO Gross marginAGIO Operating incomeAGIO Operating marginAGIO Operating cash flowAGIO Free cash flowAGIO Capital expendituresAGIO Return on equityAGIO Stock buybacksAGIO Dividends paidAGIO Total assetsAGIO Shareholders’ equityAGIO overview →